These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 680204)

  • 1. Hypertestosteronism treatment in hirsute women.
    Ansbacher R
    Fertil Steril; 1978 Aug; 30(2):246-7. PubMed ID: 680204
    [No Abstract]   [Full Text] [Related]  

  • 2. Medroxyprogesterone acetate for the evaluation of hypertestosteronism in hirsute women.
    Ettinger B; Golditch IM
    Fertil Steril; 1977 Dec; 28(12):1285-8. PubMed ID: 590535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new treatment for hirsutism.
    Correa de Oliveira RF; Novaes LP; Lima MB; Rodrigues J; Franco S; Khenaifes AI; Francalanci CP
    Ann Intern Med; 1975 Dec; 83(6):817-9. PubMed ID: 1200527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Possible influence of medroxyprogesterone on hirsutism].
    de Oliveira RF; Novais L di P; da Costa JF; Lima MB; Castilho C; Azambuja RA; Vieira Mda G; Rodrigues J; Francalanci CC
    Rev Bras Med; 1972 Apr; 29(4):198-200. PubMed ID: 5049288
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic possibilities in hirsutism].
    Huber H; Schmidt JB; Spona J
    Gynakol Rundsch; 1984; 24(3):161-7. PubMed ID: 6237038
    [No Abstract]   [Full Text] [Related]  

  • 6. [The concept of the causal therapy of hirsutism].
    Schmidt JB
    Z Hautkr; 1986 Feb; 61(4):187-96. PubMed ID: 2938348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism.
    Tiitinen A; Simberg N; Stenman UH; Ylikorkala O
    J Clin Endocrinol Metab; 1994 Aug; 79(2):447-51. PubMed ID: 8045961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential suppression of testosterone and estradiol in hirsute women with the superactive gonadotropin-releasing hormone agonist leuprolide.
    Rittmaster RS
    J Clin Endocrinol Metab; 1988 Oct; 67(4):651-5. PubMed ID: 3138274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical and hormonal effects in hirsute women treated with ketoconazole.
    Conget JI; Halperin I; Ferrer J; González-Clemente JM; Martinez-Osaba MJ; Vilardell E
    J Endocrinol Invest; 1990 Dec; 13(11):867-70. PubMed ID: 2151039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism.
    Carmina E; Janni A; Lobo RA
    J Clin Endocrinol Metab; 1994 Jan; 78(1):126-30. PubMed ID: 8288696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum prostate-specific antigen concentrations are not useful for monitoring the treatment of hirsutism with oral contraceptive pills.
    Escobar-Morreale HF; Avila S; Sancho J
    J Clin Endocrinol Metab; 2000 Jul; 85(7):2488-92. PubMed ID: 10902798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salivary testosterone as an index of antiandrogen therapy in hirsutism.
    Gómez JM; Navarro MA; Arranz B; Soler J; Bonnin MR; Montaña E
    Recenti Prog Med; 1992 Dec; 83(12):672-4. PubMed ID: 1494704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The metabolic clearance rate and origin of plasma dihydrotestosterone in man and its conversion to the 5-alpha-androstanediols.
    Mahoudeau JA; Bardin CW; Lipsett MB
    J Clin Invest; 1971 Jun; 50(6):1338-44. PubMed ID: 5103749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism.
    Lakryc EM; Motta EL; Soares JM; Haidar MA; de Lima GR; Baracat EC
    Gynecol Endocrinol; 2003 Feb; 17(1):57-63. PubMed ID: 12724020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnostic and therapeutic use of dexamethasone suppression in some cases of hirsutism with elevated plasma testosterone (author's transl)].
    Zanno C; Zagami L; Terzi I
    Ann Osp Maria Vittoria Torino; 1980; 23(7-12):428-34. PubMed ID: 7316352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel use of spironolactone: treatment of hirsutism.
    Shapiro G; Evron S
    J Clin Endocrinol Metab; 1980 Sep; 51(3):429-32. PubMed ID: 7410528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of Polycystic Ovaries by Estrogen Therapy.
    Gambrell RD
    Obstet Gynecol; 1976 May; 47(5):569-74. PubMed ID: 131262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study.
    Azziz R; Ochoa TM; Bradley EL; Potter HD; Boots LR
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3406-11. PubMed ID: 8530573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study.
    Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and management of hirsutism].
    Krysiak R; Okopień B
    Pol Merkur Lekarski; 2012 Jun; 32(192):404-9. PubMed ID: 22891568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.